Concepedia

Tarsem Moudgil

TM

7

Publications

713

Citations

7

H-Index

1994

Active since

Affiliations

Providence Portland Medical Center(Current)

Oregon Health & Science University

Cancer Research Center

UbiVac (United States)

Loyola University Medical Center

Tarsem Moudgil is an author at Providence Portland Medical Center specializing in tumor immunity, immunotherapy, and tumor immunology.

Top concepts

Publications per year

1994–2021

7

Publications

7

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas P. Morris et al. · Cancer Research · 2013 · 502 citations · Full text

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

Zipei Feng, Sachin Puri, Tarsem Moudgil et al. · Journal for ImmunoTherapy of Cancer · 2015 · 124 citations · Full text

All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.

Parkash S. Gill, Byron M. Espina, Tarsem Moudgil et al. · PubMed · 1994 · 30 citations

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Rachel E. Sanborn, Helen J. Ross, Sandra Aung et al. · Journal for ImmunoTherapy of Cancer · 2017 · 16 citations · Full text

Rows per page

1–5 of 7